Evidence map›Paper›PMID 23065205›Full record

ArticleMolecular biology reports2012

HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study.

Flora Zagouri, Theodoros N Sergentanis, Maria Gazouli, Alexandra Tsigginou, Constantine Dimitrakakis, Irene Papaspyrou, Evaggelos Eleutherakis-Papaiakovou, Dimosthenis Chrysikos, George Theodoropoulos, George C Zografos and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Association ofJCO global oncology · 2022
    Pooled it
  2. Pooled it
  3. Associations between C1772T polymorphism in hypoxia-inducible factor-1α gene and breast cancer: a meta-analysis.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Pooled it
  4. Hypoxia-inducible factor-1α (HIF-1α) C1772T polymorphism significantly contributes to the risk of malignancy from a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  5. The association between HIF-1α polymorphism and cancer risk: a systematic review and meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Journal of Cancer · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Flora ZagouriDepartment of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece.
Theodoros N Sergentanis
Maria Gazouli
Alexandra Tsigginou
Constantine Dimitrakakis
Irene Papaspyrou
Evaggelos Eleutherakis-Papaiakovou
Dimosthenis Chrysikos
George Theodoropoulos
George C Zografos
Aris Antsaklis
Athanassios-Meletios Dimopoulos
Christos A Papadimitriou

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case control study aims to investigate the role of HSP90 Gln488His (C > G), HSP70-2 P1/P2, HIF-1 alpha C1772T and HSPA8 intronic 1541-1542delGT polymorphisms as potential risk factors and/or prognostic markers for breast cancer. 113 consecutive incident cases of histologically confirmed ductal breast cancer and 124 healthy cases were recruited. The above mentioned polymorphisms were genotyped; multivariate logistic regression was performed. HSP90 GG (His/His) genotype was associated with elevated breast cancer risk. Similarly, the allele dose-response model pointed to increase in breast cancer risk per G allele. HSP70-2 P1/P2, HSPA8 intronic 1541-1542delGT and HIF-1 alpha polymorphisms were not associated with breast cancer risk, as evidenced by the dose-response allele models. The positive association between HSP90 G allele and breast cancer risk seemed to pertain to both premenopausal and postmenopausal women. With respect to survival analysis, none of the aforementioned polymorphisms was associated with either disease-free survival or overall survival. HSP90α Gln488His polymorphism seems to be a risk factor for breast cancer. On the other hand, our study did not point to excess risk conferred by HSPA8 1541-1542delGT, Hsp70-2 P1/P2 and HIF-1α C1772T.

Indexed as

Polymorphism, GeneticBreast NeoplasmsCase-Control StudiesDemographyFemaleGene FrequencyHSC70 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHumansHypoxia-Inducible Factor 1, alpha SubunitKaplan-Meier EstimateMiddle AgedOdds RatioProportional Hazards ModelsRegression AnalysisHIF1A protein, humanHSC70 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSP90AA1 protein, humanHSP90 Heat-Shock ProteinsHSPA1B protein, humanHSPA8 protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.